Skip to main content

93 7540 Pill - yellow capsule/oblong, 11mm

Pill with imprint 93 7540 is Yellow, Capsule/Oblong and has been identified as Topiramate 50 mg. It is supplied by Teva Pharmaceuticals USA.

Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7540

Topiramate 50 mg 93 7540
Topiramate 50 mg 93 7540
Topiramate 50 mg 93 7540


93 7540
50 mg
11.00 mm
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-7540 (Discontinued)
Inactive Ingredients
silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 3350, corn starch, sodium starch glycolate type A potato, titanium dioxide, ferric oxide yellow, polyvinyl alcohol, magnesium silicate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.